Filing Details
- Accession Number:
- 0001209191-11-019596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-24 19:55:55
- Reporting Period:
- 2011-03-23
- Filing Date:
- 2011-03-24
- Accepted Time:
- 2011-03-24 19:55:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-03-23 | 17,440 | $43.52 | 255,555 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was made pursuant to a 10b5-1 trading plan that was put in place in the third quarter of 2010 and in effect at the time of the transaction. The transaction was pre-determined in the trading plan to occur at specific share prices of InterMune.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $43.25 to $43.94 per share. Full information on the numbers of shares sold at each sale price is available upon request.